The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations
Authors:
- Darlene E. BerrymanDBDarlene E. Berryman
- Camilla A. M. GladCGCamilla A. M. Glad
- Edward O. ListELEdward O. List
- Gudmundur JohannssonGJGudmundur Johannsson
- 9 April 2013
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 9 (6) , 346-356
Abstract
Obesity has become one of the most common medical problems in developed countries, and this disorder is associated with high incidences of hypertension, dyslipidaemia, cardiovascular disease, type 2 diabetes mellitus and specific cancers. Growth hormone (GH) stimulates the production of insulin-like growth factor 1 in most tissues, and together GH and insulin-like growth factor 1 exert powerful collective actions on fat, protein and glucose metabolism. Clinical trials assessing the effects of GH treatment in patients with obesity have shown consistent reductions in total adipose tissue mass, in particular abdominal and visceral adipose tissue depots. Moreover, studies in patients with abdominal obesity demonstrate a marked effect of GH therapy on body composition and on lipid and glucose homeostasis. Therefore, administration of recombinant human GH or activation of endogenous GH production has great potential to influence the onset and metabolic consequences of obesity. However, the clinical use of GH is not without controversy, given conflicting results regarding its effects on glucose metabolism. This Review provides an introduction to the role of GH in obesity and summarizes clinical and preclinical data that describe how GH can influence the obese state.Keywords
This publication has 161 references indexed in Scilit:
- Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complicationsMolecular Aspects of Medicine, 2013
- Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissuesAging Cell, 2011
- Growth hormone and adipose tissue: Beyond the adipocyteGrowth Hormone & IGF Research, 2011
- Plasma proteomic profiles of bovine growth hormone transgenic mice as they ageTransgenic Research, 2011
- Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fatProceedings of the National Academy of Sciences, 2010
- Daily energy balance in growth hormone receptor/binding protein (GHR −/−) gene-disrupted mice is achieved through an increase in dark-phase energy efficiencyGrowth Hormone & IGF Research, 2010
- Aging, Depot Origin, and Preadipocyte Gene ExpressionThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Two-Year Body Composition Analyses of Long-Lived GHR Null MiceThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- Role of the GH/IGF-1 axis in lifespan and healthspan: Lessons from animal modelsGrowth Hormone & IGF Research, 2008
- Low-Dose Physiological Growth Hormone in Patients With HIV and Abdominal Fat AccumulationJAMA, 2008